99 related articles for article (PubMed ID: 16236275)
1. Inflammation, complement activation and endothelial function in stable and unstable coronary artery disease.
Kostner KM; Fahti RB; Case C; Hobson P; Tate J; Marwick TH
Clin Chim Acta; 2006 Mar; 365(1-2):129-34. PubMed ID: 16236275
[TBL] [Abstract][Full Text] [Related]
2. High sensitive C-reactive protein, adiponectin, and urine albumin excretion rate in Chinese coronary artery disease patients with different glucose tolerance status.
Gui MH; Hong J; Lü AK; Chen Y; Shen WF; Li XY; Ning G
Chin Med J (Engl); 2008 Dec; 121(24):2509-16. PubMed ID: 19187587
[TBL] [Abstract][Full Text] [Related]
3. "Poor man's risk factor": correlation between high sensitivity C-reactive protein and socio-economic class in patients of acute coronary syndrome.
Sethi R; Puri A; Makhija A; Singhal A; Ahuja A; Mukerjee S; Dwivedi SK; Narain VS; Saran RK; Puri VK
Indian Heart J; 2008; 60(3):205-9. PubMed ID: 19240308
[TBL] [Abstract][Full Text] [Related]
4. C-reactive protein associated with coronary artery disease in Iranian patients with angiographically defined coronary artery disease.
Kazemi-Bajestani SM; Ghayour-Mobarhan M; Ebrahimi M; Moohebati M; Esmaeili HA; Ferns GA
Clin Lab; 2007; 53(1-2):49-56. PubMed ID: 17323825
[TBL] [Abstract][Full Text] [Related]
5. The association between upper gastrointestinal lesions and high-sensitivity C-reactive protein in coronary artery disease patients.
Fabijanić D; Banić M; Kardum D; Sutlić Z; Simunić M; Bonacin D; Romić Z; Petricusić L; Kujundzić M
Med Sci Monit; 2009 Feb; 15(2):CR45-50. PubMed ID: 19179966
[TBL] [Abstract][Full Text] [Related]
6. Prognostic utility of lipoprotein-associated phospholipase A2 for cardiovascular outcomes in patients with stable coronary artery disease.
Sabatine MS; Morrow DA; O'Donoghue M; Jablonksi KA; Rice MM; Solomon S; Rosenberg Y; Domanski MJ; Hsia J;
Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2463-9. PubMed ID: 17766330
[TBL] [Abstract][Full Text] [Related]
7. Plasma resistin is increased in patients with unstable angina.
Hu WL; Qiao SB; Hou Q; Yuan JS
Chin Med J (Engl); 2007 May; 120(10):871-5. PubMed ID: 17543176
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease.
Sabatine MS; Morrow DA; Jablonski KA; Rice MM; Warnica JW; Domanski MJ; Hsia J; Gersh BJ; Rifai N; Ridker PM; Pfeffer MA; Braunwald E;
Circulation; 2007 Mar; 115(12):1528-36. PubMed ID: 17372173
[TBL] [Abstract][Full Text] [Related]
9. Long-term prognostic significance of high-sensitivity C-reactive protein before and after coronary angioplasty in patients with stable angina pectoris.
Gach O; Legrand V; Biessaux Y; Chapelle JP; Vanbelle S; Pierard LA
Am J Cardiol; 2007 Jan; 99(1):31-5. PubMed ID: 17196457
[TBL] [Abstract][Full Text] [Related]
10. Local release of C-reactive protein from vulnerable plaque or coronary arterial wall injured by stenting.
Inoue T; Kato T; Uchida T; Sakuma M; Nakajima A; Shibazaki M; Imoto Y; Saito M; Hashimoto S; Hikichi Y; Node K
J Am Coll Cardiol; 2005 Jul; 46(2):239-45. PubMed ID: 16022949
[TBL] [Abstract][Full Text] [Related]
11. Plasma pyridoxal 5'-phosphate and high-sensitivity C-reactive protein are independently associated with an increased risk of coronary artery disease.
Cheng CH; Lin PT; Liaw YP; Ho CC; Tsai TP; Chou MC; Huang YC
Nutrition; 2008 Mar; 24(3):239-44. PubMed ID: 18312786
[TBL] [Abstract][Full Text] [Related]
12. Is interleukin-18 correlated with endothelial dysfunction and platelet activation in patients with unstable angina?
Jurcuţ R; Arsenescu I; Puşcariu T; Uscătescu V; Jurcuţ C; Apetrei E; Ginghină C
Rom J Intern Med; 2005; 43(3-4):199-209. PubMed ID: 16812980
[TBL] [Abstract][Full Text] [Related]
13. Inter-relationships of indices of endothelial damage/dysfunction [circulating endothelial cells, von Willebrand factor and flow-mediated dilatation] to tissue factor and interleukin-6 in acute coronary syndromes.
Lee KW; Blann AD; Lip GY
Int J Cardiol; 2006 Aug; 111(2):302-8. PubMed ID: 16324758
[TBL] [Abstract][Full Text] [Related]
14. Circulating levels of high-sensitivity C-reactive protein and soluble markers of vascular endothelial cell activation in growth hormone-deficient adolescents.
Lanes R; Marcano H; Villaroel O; Gunczler P; Morillo E; Paoli M; Perez M; Maulino N; Palacios A
Horm Res; 2008; 70(4):230-5. PubMed ID: 18772596
[TBL] [Abstract][Full Text] [Related]
15. Relation of C-reactive protein to coronary collaterals in patients with stable angina pectoris and coronary artery disease.
Kerner A; Gruberg L; Goldberg A; Roguin A; Lavie P; Lavie L; Markiewicz W; Beyar R; Aronson D
Am J Cardiol; 2007 Feb; 99(4):509-12. PubMed ID: 17293195
[TBL] [Abstract][Full Text] [Related]
16. High-sensitivity C-reactive protein may be an indicator of the development of atherosclerosis in myocardial bridging.
Duygu H; Zoghi M; Nalbantgil S; Ozerkan F; Cakir C; Ertas F; Yuksek U; Akilli A; Akin M; Ergene O
Int J Cardiol; 2008 Feb; 124(2):267-70. PubMed ID: 17395309
[TBL] [Abstract][Full Text] [Related]
17. Plasma interleukin-6 and tumor necrosis factor-alpha can predict coronary endothelial dysfunction in hypertensive patients.
Naya M; Tsukamoto T; Morita K; Katoh C; Furumoto T; Fujii S; Tamaki N; Tsutsui H
Hypertens Res; 2007 Jun; 30(6):541-8. PubMed ID: 17664858
[TBL] [Abstract][Full Text] [Related]
18. Increased brachial-ankle pulse wave velocity is associated with impaired endothelial function in patients with coronary artery disease.
Liu DH; Wang Y; Liao XX; Xu MG; Wang JM; Yang Z; Chen L; Lü MD; Lu K; Tao J
Chin Med J (Engl); 2006 Nov; 119(22):1866-70. PubMed ID: 17134584
[TBL] [Abstract][Full Text] [Related]
19. Relation of high-sensitivity C-reactive protein level with coronary vasospastic angina pectoris in patients without hemodynamically significant coronary artery disease.
Hung MJ; Cherng WJ; Yang NI; Cheng CW; Li LF
Am J Cardiol; 2005 Dec; 96(11):1484-90. PubMed ID: 16310426
[TBL] [Abstract][Full Text] [Related]
20. Effect of atorvastatin on endothelial function and inflammation in long-duration type 1 diabetic patients without coronary heart disease and arterial hypertension.
Konduracka E; Galicka-Latala D; Cieslik G; Rostoff P; Fedak D; Sieradzki J; Naskalski J; Piwowarska W
Diabetes Obes Metab; 2008 Sep; 10(9):719-25. PubMed ID: 17941871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]